Summary
Objective: Survivin has been identified as a protein expressed in cancer cells and a member of the inhibitor-of-apoptosis protein family. Recent studies suggest that the expression of survivin increases during the G2/M phase of the cell cycle, and may be used in clinical prognosis. We examined whether survivin expression in human gliomas would be a correlative of prognosis. Methods: We prepared polyclonal anti-survivin serum to establish a survivin index for stained sections, using an immunohistochemical procedure, according to the method used for scoring MIB-1 index, and then stained 29 paraffin-embedded sections from surgical specimens of 29 patients who were classified into three grades of World Health Organization with the mean age of low grade astocytoma (grade II) being 34.7; anaplastic astrocytoma (grade III), 48.8; and glioblastoma multiform (grade IV), 58.4. Results: On staining with the anti-survivin antiserum, all specimens contained positive cells, but the survivin index was heterogeneous among grades. The mean percentage of immunoreactive cells in each specimen was 70.0 (SD 18.2) in grade II, 81.3 (16.5) in grade III, and 85.0 (13.6) in grade IV. Then we compared the survivin index to the MIB-1 index and found that in low-grade gliomas (grade II and III), the difference in survival times between the high and low survivin indexes was significant (P=0.007), whereas that between the high and low MIB-1 indexes was not significant (P=0.092).Conclusion: Survivin is more sensitive marker than MIB-1 for the evaluation of low-grade gliomas in that it helps to predict patient survival. Much larger glioma patient series are needed to validate the findings of our limited study.
Similar content being viewed by others
References
MK Tanwar MR Gilbert EC. Holland (2002) ArticleTitleGene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma Cancer Res 62 4364–4368 Occurrence Handle1:CAS:528:DC%2BD38XlvFelurs%3D Occurrence Handle12154041
DM Grzybicki SA. Moore (1999) ArticleTitleImplications of prognostic markers in brain tumors Clin Lab Med 19 833–847 Occurrence Handle1:STN:280:DC%2BD3c%2FjvFSisQ%3D%3D Occurrence Handle10572718
MA Heesters J Koudstaal KG Go WM. Molenaar (1999) ArticleTitleAnalysis of proliferation and apoptosis in brain gliomas; prognostic and clinical value J Neuro-oncol 44 255–266 Occurrence Handle10.1023/A:1006398613605 Occurrence Handle1:STN:280:DC%2BD3c7otlWntQ%3D%3D
AM Ralte MC Sharma AK Karak VS Mehta C. Sarkar (2001) ArticleTitleClinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors Pathol Oncol Res 7 267–278 Occurrence Handle1:STN:280:DC%2BD387kvFSgsg%3D%3D Occurrence Handle11882906
D Schiffer P Cavalla A Chio P Richiardi MT. Giordana (1997) ArticleTitleProliferative activity and prognosis of low-grade astrocytomas J Neuro-oncol 34 31–35 Occurrence Handle10.1023/A:1005755119526 Occurrence Handle1:STN:280:ByiA2MzotFQ%3D
S Shiraishi K Tada H Nakamura M Kochi H Saya J Kuratsu Y. Ushio (2002) ArticleTitleInfluence of p53 mutations on prognosis of patients with glioblastoma Cancer 95 249–257 Occurrence Handle10.1002/cncr.10677 Occurrence Handle1:CAS:528:DC%2BD38Xmt1ehtLc%3D Occurrence Handle12124823
N Ishii M Tada MF. Hamou (1999) ArticleTitleCells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable factor Oncogene 18 5870–5878 Occurrence Handle10.1038/sj.onc.1203241 Occurrence Handle1:CAS:528:DyaK1MXnt1Ortbk%3D Occurrence Handle10557074
X Di T Nishizaki K Harada K Kajiwara H Nakayama H. Ito (1997) ArticleTitleProliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1 J Exp Clin Cancer Res 16 153–157 Occurrence Handle1:STN:280:ByiH3crgsVI%3D Occurrence Handle9261740
J Vaquero M Zurita S Coca S. Oya (2002) ArticleTitleImbalance between apostain expression and proliferative index can predict survival in primary glioblastoma Acta Neurochir (Wien), 144 151–155
BJ Fisher E Naumova CC Leighton GN Naumov N Kerklviet D Fortin DR Macdonald JG Cairncross GS Bauman L. Stitt (2002) ArticleTitleKi-67: a prognostic factor for low-grade glioma? Int J Radiat Oncol Biol Phys 52 996–1001 Occurrence Handle10.1016/S0360-3016(01)02720-1 Occurrence Handle11958894
H Takahashi D Herlyn B Atkinson J Powe U Rodeck A Alavi DA Bruce H. Koprowski (1987) ArticleTitleRadioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor Cancer Res 47 3847–3850 Occurrence Handle1:CAS:528:DyaL2sXltFWrtbY%3D Occurrence Handle3594441
SL Shankar S Mani KN O’Guin ER Kandimalla S Agrawal B. Shafit-Zagardo (2001) ArticleTitleSurvivin inhibition induces human neural tumor cell death through caspase-independent and-dependent pathways J Neurochem 79 426–436 Occurrence Handle10.1046/j.1471-4159.2001.00596.x Occurrence Handle1:CAS:528:DC%2BD3MXnvFSmsLw%3D Occurrence Handle11677271
P Fortugno NR Wall A Giodini DS O’Connor J Plescia KM Padgett S Tognin PC Marchisio DC. Altieri (2002) ArticleTitleSurvivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function J Cell Sci 115 575–585 Occurrence Handle1:CAS:528:DC%2BD38**tVWmurg%3D Occurrence Handle11861764
T Yamamoto N. Tanigawa (2001) ArticleTitleThe role of survivin as a new target of diagnosis and treatment in human cancer Med Electron Microsc 34 207–212 Occurrence Handle10.1007/s007950100017 Occurrence Handle1:CAS:528:DC%2BD38XksFyrs7g%3D Occurrence Handle11956993
A Islam H Kageyama N Takada T Kawamoto H Takayasu E Isogai M Ohira K Hashizume H Kobayashi Y Kaneko A. Nakagawara (2000) ArticleTitleHigh expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma Oncogene 19 617–623 Occurrence Handle10.1038/sj.onc.1203358 Occurrence Handle1:CAS:528:DC%2BD3cXhsVOgurk%3D Occurrence Handle10698506
F Li G Ambrosini EY Chu J Plescia S Tognin PC Marchisio DC. Altieri (1998) ArticleTitleControl of apoptosis and mitotic spindle checkpoint by surviving Nature 396 580–584 Occurrence Handle10.1038/25141 Occurrence Handle1:CAS:528:DyaK1cXotVWns70%3D Occurrence Handle9859993
G Ambrosini C Adida G Sirugo DC. Altieri (1998) ArticleTitleInduction of apoptosis and inhibition of cell proliferation by survivin gene targeting J Biol Chem 273 11177–11182 Occurrence Handle10.1074/jbc.273.18.11177 Occurrence Handle1:CAS:528:DyaK1cXjtFGrsr4%3D Occurrence Handle9556606
C Chiodino AM Cesinaro D Ottani F Fantini A Giannetti GP Trentini C. Pincelli (1999) ArticleTitleExpression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin J Invest Dermatol 113 415–418 Occurrence Handle10.1046/j.1523-1747.1999.00711.x Occurrence Handle1:CAS:528:DyaK1MXlvFagtbk%3D Occurrence Handle10469343
R Konno H Yamakawa H Utsunomiya K Ito S Sato A. Yajima (2000) ArticleTitleExpression of survivin and Bcl-2 in the normal human endometrium Mol Hum Reprod 6 529–534 Occurrence Handle10.1093/molehr/6.6.529 Occurrence Handle1:CAS:528:DC%2BD3cXks1Cgt7o%3D Occurrence Handle10825370
A Chakravarti E Noll PM Black DF Finkelstein DM Finkelstein NJ Dyson JS. Loeffler (2002) ArticleTitleQuantitatively determined survivin expression levels are of prognostic value in human gliomas J Clin Oncol 20 1063–1068 Occurrence Handle10.1200/JCO.20.4.1063 Occurrence Handle1:CAS:528:DC%2BD38**tFOqurw%3D Occurrence Handle11844831
C Mahotka M Wenzel E Soringer HE Gabbert CD. Gerharz (1999) ArticleTitleSurvivin-ΔE x3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties Cancer Res 59 6097–6102
S Enestrom L Vavruch B Franlund B. Nordenskjold (1998) ArticleTitleKi-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas Neurochorirurgie 44 25–30 Occurrence Handle1:STN:280:DyaK1cvivFyksw%3D%3D
D Marie Y Liu SA Moore HG Brown JF Silverman F D’Amico SS. Raab (2001) ArticleTitleInterobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors Cancer 92 2720–2726 Occurrence Handle1:STN:280:DC%2BD3Mnps1ejtg%3D%3D Occurrence Handle11745208
EM Conway S Pollefeyt J Cornelissen I DeBaere M Steiner-Mosonyi K Ong M Baens D Collen AC. Schuh (2000) ArticleTitleThree differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions Blood 95 1435–1442 Occurrence Handle1:CAS:528:DC%2BD3cXhtFKitLc%3D Occurrence Handle10666222
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uematsu, M., Ohsawa, I., Aokage, T. et al. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. J Neurooncol 72, 231–238 (2005). https://doi.org/10.1007/s11060-004-2353-3
Issue Date:
DOI: https://doi.org/10.1007/s11060-004-2353-3